Dihexa
PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, Hexanoyl-Tyr-Ile-Ahx-NH2, ATH-1001
A synthetic angiotensin IV analogue with no human study found. Its mechanism paper was retracted in 2025; FDA lists it as a withdrawn compounding nomination.